Your browser doesn't support javascript.
loading
RETRACTED: LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN.
Hua, Xing; Liu, Zhen; Zhou, Min; Tian, Yan; Zhao, Pei-Pei; Pan, Wen-Hai; Li, Chao-Xia; Huang, Xiao-Xiao; Liao, Ze-Xiao; Xian, Qi; Chen, Bo; Hu, Yue; Leng, Lei; Fang, Xiao-Wei; Yu, Li-Na.
Afiliação
  • Hua X; Departments of Pathology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou 510220, P.R. China.
  • Liu Z; Department of Pathology, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550025, P.R. China.
  • Zhou M; Department of Otolaryngology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510006, P.R. China.
  • Tian Y; Department of pathology, School of Basic Medical Sciences, Southern Medical University, Guanghou 510515, P.R.China; Department of pathology, Nanfang Hospital, Guanghou 510515, P.R. China; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou 510515, P.R. China.
  • Zhao PP; Department of pathology, School of Basic Medical Sciences, Southern Medical University, Guanghou 510515, P.R.China; Department of pathology, Nanfang Hospital, Guanghou 510515, P.R. China; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou 510515, P.R. China.
  • Pan WH; Departments of Pathology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou 510220, P.R. China.
  • Li CX; Departments of Pathology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou 510220, P.R. China.
  • Huang XX; Departments of Pathology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou 510220, P.R. China.
  • Liao ZX; Departments of Pathology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou 510220, P.R. China.
  • Xian Q; Departments of Pathology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou 510220, P.R. China.
  • Chen B; Departments of Pathology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou 510220, P.R. China.
  • Hu Y; Departments of Pathology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou 510220, P.R. China.
  • Leng L; Departments of Pathology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou 510220, P.R. China.
  • Fang XW; Departments of Pathology, Guangzhou Red Cross Hospital, Medical College, Jinan University, Guangzhou 510220, P.R. China.
  • Yu LN; Department of pathology, School of Basic Medical Sciences, Southern Medical University, Guanghou 510515, P.R.China; Department of pathology, Nanfang Hospital, Guanghou 510515, P.R. China; Guangdong Provincial Key Laboratory of Molecular Tumor Pathology, Guangzhou 510515, P.R. China. Electronic addre
EBioMedicine ; 50: 178-190, 2019 12.
Article em En | MEDLINE | ID: mdl-31727599
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Moléculas de Adesão Celular Neuronais / Regulação Neoplásica da Expressão Gênica / RNA Antissenso / MicroRNAs / Interferência de RNA / Decorina Tipo de estudo: Prognostic_studies Aspecto: Ethics Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: EBioMedicine Ano de publicação: 2019 Tipo de documento: Article País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Moléculas de Adesão Celular Neuronais / Regulação Neoplásica da Expressão Gênica / RNA Antissenso / MicroRNAs / Interferência de RNA / Decorina Tipo de estudo: Prognostic_studies Aspecto: Ethics Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: EBioMedicine Ano de publicação: 2019 Tipo de documento: Article País de publicação: Holanda